about
Gender disparities in ocular inflammatory disordersChoroidal imaging: A review.Periocular corticosteroid injections in uveitis: effects and complications.Choroidal thickness profi le in healthy Indian subjects.A case of vogt-koyanagi-harada disease associated with polycystic ovary syndrome.Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.Primary diffuse large B-cell lymphoma of the spleen with coincident serous retinal detachments responsive to corticosteroids.Correlation between Retinal Changes and Visual Function in Late-Stage Vogt-Koyanagi-Harada Disease: An Optical Coherence Tomography Study.Choroidal circulation impairment during the anterior recurrence of Vogt-Koyanagi-Harada disease confirmed with indocyanine green angiography and laser speckle flowgraphy.Choroidal thickness profile in healthy Indian children.Repeatability and reproducibility of manual choroidal volume measurements using enhanced depth imaging optical coherence tomography.Understanding the role of aldose reductase in ocular inflammation.Vogt-Koyanagi-Harada disease in Thailand.Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.Vogt-Koyanagi-Harada syndrome presenting with encephalopathyVogt-Koyanagi-Harada syndrome presenting with encephalopathyA Focus on the Epidemiology of Uveitis.Vogt-Koyanagi-Harada disease: headache as an initial manifestation.Vogt-Koyanagi-Harada syndrome and Crohn's disease: an exceptional association.Vogt-Koyanagi-Harada disease: clinical and demographic characteristics of patients in a specialized eye hospital in Turkey.Vogt-Koyanagi-Harada disease presenting as acute angle closure glaucoma at onset.Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.Treatment challenges in an atypical presentation of tubulointerstitial nephritis and uveitis (TINU).Vogt-Koyanagi-Harada Disease
P2860
Q26995402-83E42D0E-71A0-47B8-A62B-B89C64520509Q33620471-12EFFC8D-FFC7-4AEE-B22A-808FE0034082Q34624389-0D1AC404-FAEF-42E0-87B8-54DA7020FC14Q34909559-CEF65FBA-C278-43D0-88FE-006606D2F0E2Q35119986-56C427CC-2D3E-4D4D-9E38-3BEB29BCCE85Q35833086-58558C29-8546-438B-A9A4-83DA43A4EF26Q35945515-B26A938B-1838-4AC8-B3D6-85099E0C17FAQ35957885-83D32FED-2195-4974-8FEB-4A3146748A5EQ35990306-6B22F291-3F90-4E05-A5E6-E04F7B067C98Q35999611-5B3DF9DD-A252-40B7-8177-79DBD4FECA6FQ37716564-FF1F0441-E009-47B6-832B-7754B6F5F957Q37774015-C0C5BAA2-3160-46FA-BB46-1CA2843DF8A5Q38060844-2F07C4A3-994E-454B-865F-A482223781ECQ38591885-7F3A8A59-D61A-4B89-BBD2-42897A89BA4DQ38842293-33599931-C09F-4591-9107-088D683F226FQ39289618-24BF14DF-37B9-4F8D-8082-9810928C90C8Q39551002-BA3BE068-9F13-4EF8-8F7C-6D63EDB2A709Q42327494-90D17748-7BCE-41D7-91E1-76BE34F2D911Q50233732-B95F2871-EC6B-4BDB-9E73-FF6549D22531Q51177631-19D26364-15AD-47B5-9E4C-347A05E7983EQ51350677-3D82483D-00FB-43D4-80CE-AAF85B1A8966Q53754593-8A144D3D-530E-4943-845E-FC9D59BCB4E5Q55406515-A85E05B7-3536-4E3C-B588-093C7EED06B3Q55982733-BF251807-9DD9-4E8E-8FDB-D9DDCFB05702
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Vogt-Koyanagi-Harada disease.
@ast
Vogt-Koyanagi-Harada disease.
@en
Vogt-Koyanagi-Harada disease.
@nl
type
label
Vogt-Koyanagi-Harada disease.
@ast
Vogt-Koyanagi-Harada disease.
@en
Vogt-Koyanagi-Harada disease.
@nl
prefLabel
Vogt-Koyanagi-Harada disease.
@ast
Vogt-Koyanagi-Harada disease.
@en
Vogt-Koyanagi-Harada disease.
@nl
P2093
P1476
Vogt-Koyanagi-Harada disease.
@en
P2093
P304
P356
10.1097/00055735-200012000-00009
P577
2000-12-01T00:00:00Z